New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing ...

Radical prostatectomy does not ensure a cure, with one in three men experiencing cancer recurrence and elevated PSA levels within 10 years post-surgery. Significant side effects of prostate removal ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

With Men’s Health Week approaching, it is a good time to encourage open discussions about various health conditions, particularly prostate health. Driven by embarrassment, misconceptions, and a lack ...

RP appears more protective than RT among men with actively treated incidental prostate cancer. Patients with higher-grade incidentally discovered prostate cancer (IPCa) may have better outcomes if ...

BARCELONA, Spain — Men who score high for the personality trait of neuroticism tend to have worse recovery and suffer from more adverse events following radical prostatectomy than men with more with a ...